• PsyBio Therapeutics Corp. (PSYB) has closed the second tranche of a non-brokered private placement
  • Under the second tranche, the company issued 5,533,785 for gross proceeds of $276,689
  • Together with the first tranche, the company has raised gross proceeds of $909,970
  • PsyBio Therapeutics is an intellectual property-driven biotechnology company
  • Psybio Therapeutics Corp. (PSYB) opened trading at C$0.07

PsyBio Therapeutics Corp. (PSYB) has closed the second tranche of a non-brokered private placement.

Under the second tranche, the company issued 5,533,785 units priced at $0.05 per unit for gross proceeds of $276,689. Together with the first tranche, the company has raised gross proceeds of $909,970.

Each unit consists of one subordinate voting share and one common share purchase warrant exercisable at $0.10 per share for 24 months.

Warrants are subject to an acceleration clause.

All securities issued are subject to a statutory four-month hold period.

PsyBio Therapeutics is an intellectual property-driven biotechnology company developing psycho-targeted therapeutics to improve mental health and neurological conditions.

Psybio Therapeutics Corp. (PSYB) opened trading at C$0.07.


More From The Market Online

Usha Resources begins phase 4 fieldwork at White Willow Project

Usha Resources (TSXV:USHA) has begun the fourth phase of fieldwork at its White Willow Lithium Project in Ontario following phase 3 work.

@ the Bell: Stocks level-out ahead of Easter long weekend

A rebound in oil prices and growth in metal prices helped push Canada’s main stock index higher as investors await economic data.